{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:18:08Z","timestamp":1790561888524,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.thromres.2023.11.008","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T03:24:35Z","timestamp":1699500275000},"page":"123-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry"],"prefix":"10.1016","volume":"232","author":[{"given":"Adrian C.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Oropallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Z.","family":"Goldhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg E.","family":"Fluharty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.G.","family":"Turpie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Kayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4 SUPPL","key":"10.1016\/j.thromres.2023.11.008_bb0005","article-title":"Venous thromboembolism. A public health concern","volume":"38","author":"Beckman","year":"2010","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.thromres.2023.11.008_bb0010","first-page":"197","article-title":"Current estimates of the incidence of acute venous thromboembolic disease in Canada: a meta-analysis","author":"Payne","year":"2021","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.thromres.2023.11.008_bb0015","article-title":"Characteristics and management of patients with venous thromboembolism: the GARFIELD-VTE Registry","volume":"119","author":"Ageno","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2023.11.008_bb0020","article-title":"Thrombosis: a major contributor to global disease burden","volume":"40","author":"Raskob","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2023.11.008_bb0025","series-title":"Preventing Hospital-associated Venous Thromboembolism: A Guide for Effective Quality Improvement","author":"Maynard","year":"2016"},{"issue":"10","key":"10.1016\/j.thromres.2023.11.008_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14548","article-title":"Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients","volume":"17","author":"Haas","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"Suppl. 23","key":"10.1016\/j.thromres.2023.11.008_bb0035","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"issue":"Suppl. 4","key":"10.1016\/j.thromres.2023.11.008_bb0040","article-title":"Effects of race and ethnicity on the incidence of venous thromboembolism","volume":"123","author":"White","year":"2009","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2023.11.008_bb0045","article-title":"Risk factors for venous thrombosis in the black population","volume":"90","author":"Patel","year":"2003","journal-title":"Thromb. Haemost."},{"issue":"2 SUPPL","key":"10.1016\/j.thromres.2023.11.008_bb0050","article-title":"Prevention of VTE in orthopedic surgery patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.thromres.2023.11.008_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.thromres.2023.11.008_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST Guideline and Expert Panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.thromres.2023.11.008_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004267","article-title":"Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial (Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)","volume":"10","author":"Link","year":"2017","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"5","key":"10.1016\/j.thromres.2023.11.008_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.111.055970","article-title":"Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized evaluation of long-term anticoagulation therapy) trial","volume":"125","author":"Hohnloser","year":"2012","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.thromres.2023.11.008_bb0075","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.thromres.2023.11.008_bb0080","article-title":"Global anticoagulant registry in the field - venous thromboembolism (Garfield-VTE): rationale and design","volume":"116","author":"Weitz","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.11.008_bb0085","series-title":"The Danish Health Care System, 2015. 2015 International Profiles of Health Care Systems","author":"Vrangbaek","year":"2016"},{"issue":"2","key":"10.1016\/j.thromres.2023.11.008_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euu225","article-title":"Non-vitamin K antagonist oral anticoagulation agents in anticoagulant na\u00efve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013","volume":"17","author":"Olesen","year":"2014","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.thromres.2023.11.008_bb0095","article-title":"Prior authorization and Canadian public utilization of direct-acting oral anticoagulants","volume":"13","author":"Gao","year":"2017","journal-title":"Healthcare Policy."},{"key":"10.1016\/j.thromres.2023.11.008_bb0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.37288","article-title":"Clinician trends in prescribing direct oral anticoagulants for US Medicare beneficiaries","author":"Wheelock","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.thromres.2023.11.008_bb0105","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-020-05904-0","article-title":"Oral anticoagulant utilization in the United States and United Kingdom","volume":"35","author":"Colacci","year":"2020","journal-title":"J. Gen. Intern. Med."},{"issue":"10","key":"10.1016\/j.thromres.2023.11.008_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2018.1150","article-title":"Health care spending in the United States and other high-income countries","volume":"319","author":"Papanicolas","year":"2018","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.thromres.2023.11.008_bb0115","first-page":"22","article-title":"Trends in oral anticoagulant use among 436864 patients with atrial fibrillation in community practice","volume":"15","author":"Navar","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"14","key":"10.1016\/j.thromres.2023.11.008_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.119.040580","article-title":"Evolution of Medicare formulary coverage changes for antithrombotic therapies after guideline updates","volume":"140","author":"Dayoub","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.thromres.2023.11.008_bb0125","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-009-0365-8","article-title":"The role of ethnicity, age and gender in venous thromboembolism","volume":"29","author":"Montagnana","year":"2010","journal-title":"J. Thromb. Thrombolysis"},{"issue":"5","key":"10.1016\/j.thromres.2023.11.008_bb0130","article-title":"Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms","volume":"15","author":"Wattanakit","year":"2009","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"9","key":"10.1016\/j.thromres.2023.11.008_bb0135","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.164.9.963","article-title":"Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study","volume":"164","author":"Alikhan","year":"2004","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.thromres.2023.11.008_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/j.1751-7133.2010.00148.x","article-title":"Venous thromboembolic disease in congestive heart failure","volume":"16","author":"Dean","year":"2010","journal-title":"Congest. Heart Fail."},{"issue":"Supplement 1","key":"10.1016\/j.thromres.2023.11.008_bb0145","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2020-141961","article-title":"Prior history of venous thromboembolism is a significant risk factor for recurrence of thrombosis after cancer diagnosis","volume":"136","author":"Kapoor","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2023.11.008_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2007.01.003","article-title":"Platelet activation in acute, decompensated congestive heart failure","volume":"120","author":"Chung","year":"2007","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2023.11.008_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/jth.12124","article-title":"Diagnostic management of acute deep vein thrombosis and pulmonary embolism","volume":"11","author":"Huisman","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2023.11.008_bb0160","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00220114","article-title":"Venous thromboembolism in patients immobilised at home","volume":"45","author":"L\u00f3pez-Reyes","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.thromres.2023.11.008_bb0165","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.11.008_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007230","article-title":"Bleeding risk of direct oral anticoagulants in patients with heart failure and atrial fibrillation","author":"Jackevicius","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"19","key":"10.1016\/j.thromres.2023.11.008_bb0175","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.thromres.2023.11.008_bb0180","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.thromres.2023.11.008_bb0185","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-144-3-200602070-00003","article-title":"Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism","volume":"144","author":"Roy","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.thromres.2023.11.008_bb0190","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-014-0497-0","article-title":"Catheter-based therapies for deep vein thrombosis","volume":"16","author":"Razavi","year":"2014","journal-title":"Curr. Cardiol. Rep."},{"issue":"14","key":"10.1016\/j.thromres.2023.11.008_bb0195","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-17-00437","article-title":"Catheter-based therapies in acute pulmonary embolism","volume":"13","author":"Schultz","year":"2018","journal-title":"EuroIntervention"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823003146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823003146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:52:21Z","timestamp":1758736341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823003146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":39,"alternative-id":["S0049384823003146"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.11.008","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}